![]() |
市場調查報告書
商品編碼
1773348
嬰兒奶粉市場機會、成長動力、產業趨勢分析及2025-2034年預測Baby Milk Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球嬰兒奶粉市場規模為 165 億美元,預計到 2034 年將以 5.4% 的複合年成長率成長至 277 億美元。這個市場有助於支持嬰兒營養,特別是對於無法或選擇不哺乳的母親。奶粉種類繁多,包括嬰兒配方奶粉(適用於 6 個月以下的嬰兒)、較大嬰兒配方奶粉(6 至 12 個月)、成長奶粉(12 至 36 個月),以及針對乳糖不耐症、早產和其他敏感健康需求開發的專用產品。這些乳製品經過科學配製,可模擬母乳,提供健康成長所必需的營養素,例如碳水化合物、脂肪、蛋白質、維生素和礦物質。職業母親比例的提高、透過數位和零售平台獲取產品管道的便利性以及人們對清潔標籤和有機替代品日益成長的興趣,共同推動了市場的發展勢頭。
不斷變化的消費者偏好正在重塑嬰兒奶粉類別,促使企業提供安全、高效、營養豐富的選擇,以符合注重健康的育兒理念。現今的育兒者不僅追求基本的營養,更越來越關注產品透明度、清潔標籤、有機採購以及不含人工添加劑。這種轉變促使製造商不斷改進產品配方,添加非基因改造成分、有益於腸道健康的益生菌,以及針對乳糖不耐症、過敏或早產等特殊需求的配方。如今,父母擁有更豐富的訊息,並要求產品擁有臨床研究和醫學認證的支援。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 165億美元 |
預測值 | 277億美元 |
複合年成長率 | 5.4% |
嬰兒配方奶粉市場在2024年佔據40.2%的市場佔有率,預計到2034年將保持領先地位,複合年成長率達5.6%。在嬰兒出生後的最初六個月,父母非常依賴這個市場,因為此時嬰兒最脆弱,需要精心均衡的營養方案。這些配方奶粉旨在提供全面的營養,與母乳中的關鍵營養成分非常接近。隨著護理人員健康意識的不斷提高,對高品質且經醫學認證的嬰兒配方奶粉的需求仍然是該類別的強勁驅動力,尤其是在城市家庭中。
碳水化合物細分市場在2024年佔據28.1%的佔有率,預計到2034年將以5.5%的複合年成長率成長。乳糖是大多數嬰兒配方奶粉中的主要碳水化合物,是重要的能量來源,並支持大腦發育和腸道菌叢健康等重要功能。它還有助於增強鈣的吸收,促進骨骼發育。雖然蛋白質、維生素、脂肪和益生元等其他成分對免疫防禦、代謝功能和組織修復至關重要,但碳水化合物因其對嬰兒生長發育的基礎性貢獻而始終佔據核心地位。它們與其他營養素的協同作用,凸顯了其在產品配方中持續佔據重要地位。
2024年,美國嬰兒奶粉市場規模達39億美元,預計2034年將以4.4%的複合年成長率成長。美國擁有成熟的配方奶粉生產產業、廣泛的產品可及性以及高度知情的消費者群體。受不斷變化的飲食需求和充足的產品供應推動,標準配方奶粉和專用配方奶粉的需求持續保持高位。雅培實驗室、雀巢和美贊臣(利潔時)等知名企業的存在持續影響著創新週期和供應鏈實力,使美國成為該地區嬰兒奶粉產業的基石。
塑造全球嬰兒奶粉市場的關鍵公司包括雅培實驗室、Arla Foods Amba、貝拉米有機、合生元(健合集團)和澳優乳業有限公司。為了鞏固其市場地位,嬰兒奶粉產業的領導者正在利用專注於產品創新、監管協調和消費者教育的策略。許多企業正在投資研發,推出添加了益生菌、有機成分和無過敏原成分的配方。各公司也致力於透過加強與電商平台、藥局和醫療保健網路的合作來擴大分銷範圍。圍繞包裝和清潔標籤認證的永續發展措施已成為關鍵的差異化因素,尤其是在注重健康的父母群體中。
The Global Baby Milk Market was valued at USD 16.5 billion in 2024 and is estimated to grow at a CAGR of 5.4% to reach USD 27.7 billion by 2034. This market helps in supporting infant nutrition, especially for mothers who are unable or choose not to breastfeed. The category includes various formulations such as infant formula (for babies up to 6 months), follow-on formula (6 to 12 months), growing-up milk (12 to 36 months), and specialized products developed for lactose intolerance, premature birth, and other sensitive health needs. These milk products are scientifically engineered to simulate breast milk, delivering essential nutrients such as carbohydrates, fats, proteins, vitamins, and minerals necessary for healthy growth. The market's momentum is being fueled by higher rates of working mothers, improved access to products through digital and retail platforms, and growing interest in clean-label and organic alternatives.
Evolving consumer preferences are reshaping the baby milk category, pushing companies to deliver safe, efficient, and nutrient-rich options that align with health-conscious parenting. Today's caregivers are not only looking for basic nutrition but are increasingly concerned about product transparency, clean labels, organic sourcing, and the absence of artificial additives. This shift has led manufacturers to reformulate offerings with non-GMO ingredients, probiotics for gut health, and formulas tailored to specific needs such as lactose intolerance, allergies, or premature birth. Parents are now more informed and demand products backed by clinical research and medical endorsements.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $16.5 Billion |
Forecast Value | $27.7 Billion |
CAGR | 5.4% |
The infant formula segment held a 40.2% share in 2024 and is anticipated to maintain its leadership, growing at a CAGR of 5.6% through 2034. Parents rely heavily on this segment during the initial six months of life when infants are most vulnerable and need a carefully balanced nutritional solution. These formulas are crafted to deliver complete nourishment, closely mimicking the key nutrients found in breast milk. With health awareness rising among caregivers, demand for high-quality and medically approved infant formula remains a strong driver for the category, especially in urban households.
The carbohydrates segment held a 28.1% share in 2024 and is projected to rise at a 5.5% CAGR by 2034. Lactose, the primary carbohydrate in most baby milk formulas, serves as a critical energy source and supports vital functions such as brain development and healthy gut flora. It also plays a role in enhancing calcium absorption and promoting skeletal development. While other ingredients such as proteins, vitamins, fats, and prebiotics are essential for immune defense, metabolic function, and tissue repair, carbohydrates remain central due to their foundational contribution to infant growth. Their synergistic effect with other nutrients underscores their continued prominence in product formulations.
United States Baby Milk Market generated USD 3.9 billion in 2024 and is projected to grow at a 4.4% CAGR by 2034. The U.S. benefits from a mature formula manufacturing sector, wide-scale product accessibility, and a highly informed consumer base. Demand remains consistently high for both standard and specialized formulas, driven by evolving dietary needs and strong product availability. The presence of established players such as Abbott Laboratories, Nestle, and Mead Johnson (Reckitt) continues to influence innovation cycles and supply chain strength, making the U.S. a cornerstone of the baby milk industry in the region.
Key companies shaping the Global Baby Milk Market include Abbott Laboratories, Arla Foods Amba, Bellamy's Organic, Biostime (H&H Group), and Ausnutria Dairy Corporation Ltd. To reinforce their position, leading players in the baby milk sector are leveraging strategies that focus on product innovation, regulatory alignment, and consumer education. Many are investing in R&D to introduce formulations fortified with probiotics, organic ingredients, and allergen-free components. Companies are also working to expand their distribution reach by strengthening partnerships with e-commerce platforms, pharmacies, and healthcare networks. Sustainability initiatives around packaging and clean-label certifications have become key differentiators, especially among health-conscious parents.